| 前收市價 | 0.9500 |
| 開市 | 0.7000 |
| 買盤 | 0.3000 |
| 賣出價 | 0.8500 |
| 拍板 | 40.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 0.7000 - 0.9500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 2.28k |
Investor's Business DailyAfter Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
ZacksImmunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Investor's Business DailyBiohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
